Evidence map›Paper›PMID 23913690›Full record

ArticleThe Journal of biological chemistry2013

Agonist-biased trafficking of somatostatin receptor 2A in enteric neurons.

Peishen Zhao, Meritxell Canals, Jane E Murphy, Diana Klingler, Emily M Eriksson, Juan-Carlos Pelayo, Markus Hardt, Nigel W Bunnett, Daniel P Poole

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Location bias: A "Hidden Variable" in GPCR pharmacology.BioEssays : news and reviews in molecular, cellular and developmental biology · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. Biased signaling by endogenous opioid peptides.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  7. Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours.European journal of nuclear medicine and molecular imaging · 2020
    Review
  8. Article
  9. Review
  10. Inflammation-associated changes in DOR expression and function in the mouse colon.American journal of physiology. Gastrointestinal and liver physiology · 2018
    Article
  11. Therapeutic Targeting of Endosomal G-Protein-Coupled Receptors.Trends in pharmacological sciences · 2018
    Review
  12. Review
  13. Distribution and trafficking of the μ-opioid receptor in enteric neurons of the guinea pig.American journal of physiology. Gastrointestinal and liver physiology · 2016
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Peishen ZhaoFrom the Monash Institute of Pharmaceutical Sciences, 381 Royal Parade, Parkville, Victoria 3052, Australia.
Meritxell CanalsFrom the Monash Institute of Pharmaceutical Sciences, 381 Royal Parade, Parkville, Victoria 3052, Australia.
Jane E Murphythe Department of Surgery, University of California, San Francisco, San Francisco, California 94143.
Diana Klinglerthe Department of Applied Oral Sciences, The Forsyth Institute, Cambridge, Massachusetts 02142, and.
Emily M Erikssonthe Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California 94110.
Juan-Carlos Pelayothe Department of Surgery, University of California, San Francisco, San Francisco, California 94143.
Markus Hardtthe Department of Applied Oral Sciences, The Forsyth Institute, Cambridge, Massachusetts 02142, and.
Nigel W BunnettFrom the Monash Institute of Pharmaceutical Sciences, 381 Royal Parade, Parkville, Victoria 3052, Australia,. Electronic address: Nigel.Bunnett@Monash.edu.
Daniel P PooleFrom the Monash Institute of Pharmaceutical Sciences, 381 Royal Parade, Parkville, Victoria 3052, Australia,. Electronic address: Daniel.Poole@Monash.edu.

Funding

The Role of Proteases and Peptides in Cancer PainR01DE019796 · NIDCR · NEW YORK UNIVERSITY · PI HARDT, MARKUS, SCHMIDT, BRIAN L · 2010 to 2014
$2.8M
NIDCR NIH HHS 1R01DE019796NIDCR NIH HHS R01 DE019796
6 · The paper itself

Abstract

Somatostatin (SST) 14 and SST 28 activate somatostatin 2A receptors (SSTR2A) on enteric neurons to control gut functions. SST analogs are treatments of neuroendocrine and bleeding disorders, cancer, and diarrhea, with gastrointestinal side effects of constipation, abdominal pain, and nausea. How endogenous agonists and drugs differentially regulate neuronal SSTR2A is unexplored. We evaluated SSTR2A trafficking in murine myenteric neurons and neuroendocrine AtT-20 cells by microscopy and determined whether agonist degradation by endosomal endothelin-converting enzyme 1 (ECE-1) controls SSTR2A trafficking and association with β-arrestins, key regulators of receptors. SST-14, SST-28, and peptide analogs (octreotide, lanreotide, and vapreotide) stimulated clathrin- and dynamin-mediated internalization of SSTR2A, which colocalized with ECE-1 in endosomes and the Golgi. After incubation with SST-14, SSTR2A recycled to the plasma membrane, which required active ECE-1 and an intact Golgi. SSTR2A activated by SST-28, octreotide, lanreotide, or vapreotide was retained within the Golgi and did not recycle. Although ECE-1 rapidly degraded SST-14, SST-28 was resistant to degradation, and ECE-1 did not degrade SST analogs. SST-14 and SST-28 induced transient interactions between SSTR2A and β-arrestins that were stabilized by an ECE-1 inhibitor. Octreotide induced sustained SSTR2A/β-arrestin interactions that were not regulated by ECE-1. Thus, when activated by SST-14, SSTR2A internalizes and recycles via the Golgi, which requires ECE-1 degradation of SST-14 and receptor dissociation from β-arrestins. After activation by ECE-1-resistant SST-28 and analogs, SSTR2A remains in endosomes because of sustained β-arrestin interactions. Therapeutic SST analogs are ECE-1-resistant and retain SSTR2A in endosomes, which may explain their long-lasting actions.

Indexed as

ProteolysisAnimalsArrestinsAspartic Acid Endopeptidasesbeta-ArrestinsCell Line, TumorEndosomesEndothelin-Converting EnzymesEnteric Nervous SystemFemaleGastrointestinal AgentsGolgi ApparatusMaleMetalloendopeptidasesMiceNeuronsArrestinsAspartic Acid Endopeptidasesbeta-ArrestinsEce1 protein, mouseEndothelin-Converting EnzymesGastrointestinal AgentsMetalloendopeptidasesOctreotideReceptors, SomatostatinSomatostatinSomatostatin-28somatostatin receptor 2ArrestinEndocytosisEndothelin-converting EnzymeNeuronsNeuropeptideReceptor RecyclingSomatostatin

Identifiers

PMID23913690
PMCPMC3764777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.